The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
Bluebird Bio's Not-So-Happy Song and What It Says to the California Stem Cell Agency

Bluebird Bio's Not-So-Happy Song and What It Says to the California Stem Cell Agency

$3 million treatments and the fates of Bluebird and CIRM

David Jensen's avatar
David Jensen
Oct 05, 2022
∙ Paid
1

Share this post

User's avatar
The California Stem Cell Report
Bluebird Bio's Not-So-Happy Song and What It Says to the California Stem Cell Agency
Share
Bluebird Bio image

A Massachusetts firm that once flirted with California’s $12 billion stem cell agency is now providing a bit of a lesson for the Golden State’s program.

The firm is Bluebird Bio, which is ready to become the “seller of the two most expensive drugs” in the world at nearly $3 million each. Sounds lucrative, right? Maybe not. 

“World’s Most…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share